| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 6.50e-10 | 16 | 17 | 4 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.13e-09 | 21 | 17 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | calcium ion binding | 6.80e-08 | 749 | 17 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 6.98e-07 | 85 | 17 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 3.30e-06 | 35 | 17 | 3 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 3.30e-06 | 35 | 17 | 3 | GO:0071814 | |
| GeneOntologyMolecularFunction | collagen V binding | 6.81e-06 | 5 | 17 | 2 | GO:0070052 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.65e-05 | 188 | 17 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 8.35e-05 | 102 | 17 | 3 | GO:0001540 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 1.04e-04 | 18 | 17 | 2 | GO:0030169 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 2.19e-04 | 26 | 17 | 2 | GO:0050431 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.93e-04 | 156 | 17 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 3.77e-04 | 34 | 17 | 2 | GO:0050750 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 4.96e-04 | 39 | 17 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | amide binding | 1.93e-03 | 299 | 17 | 3 | GO:0033218 | |
| GeneOntologyMolecularFunction | collagen binding | 2.12e-03 | 81 | 17 | 2 | GO:0005518 | |
| GeneOntologyMolecularFunction | peptide binding | 2.31e-03 | 318 | 17 | 3 | GO:0042277 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 4.41e-03 | 1353 | 17 | 5 | GO:0004888 | |
| GeneOntologyMolecularFunction | structural molecule activity | 5.88e-03 | 891 | 17 | 4 | GO:0005198 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 6.45e-03 | 143 | 17 | 2 | GO:0017124 | |
| GeneOntologyMolecularFunction | cytokine binding | 7.73e-03 | 157 | 17 | 2 | GO:0019955 | |
| GeneOntologyMolecularFunction | integrin binding | 9.53e-03 | 175 | 17 | 2 | GO:0005178 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 1.01e-02 | 180 | 17 | 2 | GO:0004866 | |
| GeneOntologyMolecularFunction | protease binding | 1.02e-02 | 181 | 17 | 2 | GO:0002020 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 1.08e-02 | 187 | 17 | 2 | GO:0030414 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 1.24e-02 | 201 | 17 | 2 | GO:0061135 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 1.98e-02 | 257 | 17 | 2 | GO:0061134 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 2.14e-02 | 268 | 17 | 2 | GO:0005539 | |
| GeneOntologyBiologicalProcess | endocytosis | 2.22e-06 | 827 | 17 | 7 | GO:0006897 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 7.37e-06 | 47 | 17 | 3 | GO:0060351 | |
| GeneOntologyBiologicalProcess | import into cell | 1.25e-05 | 1074 | 17 | 7 | GO:0098657 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 3.54e-05 | 79 | 17 | 3 | GO:0060350 | |
| GeneOntologyBiologicalProcess | protein maturation | 1.10e-04 | 619 | 17 | 5 | GO:0051604 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 1.36e-04 | 124 | 17 | 3 | GO:0060349 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 1.41e-04 | 337 | 17 | 4 | GO:0006898 | |
| GeneOntologyBiologicalProcess | connective tissue development | 1.51e-04 | 343 | 17 | 4 | GO:0061448 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.58e-04 | 347 | 17 | 4 | GO:0090092 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 2.38e-04 | 150 | 17 | 3 | GO:0090288 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 3.04e-04 | 412 | 17 | 4 | GO:0090287 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 4.07e-04 | 445 | 17 | 4 | GO:0141091 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 4.80e-04 | 850 | 17 | 5 | GO:0071363 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 5.50e-04 | 482 | 17 | 4 | GO:0007178 | |
| GeneOntologyBiologicalProcess | response to growth factor | 5.72e-04 | 883 | 17 | 5 | GO:0070848 | |
| GeneOntologyBiologicalProcess | cartilage development | 9.72e-04 | 243 | 17 | 3 | GO:0051216 | |
| GeneOntologyBiologicalProcess | bone development | 1.23e-03 | 264 | 17 | 3 | GO:0060348 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 1.42e-03 | 277 | 17 | 3 | GO:0048705 | |
| GeneOntologyBiologicalProcess | protein processing | 1.54e-03 | 285 | 17 | 3 | GO:0016485 | |
| GeneOntologyBiologicalProcess | axon guidance | 1.54e-03 | 285 | 17 | 3 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.55e-03 | 286 | 17 | 3 | GO:0097485 | |
| GeneOntologyBiologicalProcess | amyloid precursor protein catabolic process | 1.62e-03 | 73 | 17 | 2 | GO:0042987 | |
| GeneOntologyCellularComponent | cell surface | 9.81e-07 | 1111 | 17 | 8 | GO:0009986 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.52e-06 | 530 | 17 | 6 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 8.59e-06 | 656 | 17 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 8.75e-06 | 658 | 17 | 6 | GO:0030312 | |
| MousePheno | abnormal heart left ventricle morphology | 1.33e-06 | 369 | 15 | 6 | MP:0003921 | |
| MousePheno | cardiac hypertrophy | 1.38e-06 | 196 | 15 | 5 | MP:0001625 | |
| MousePheno | abnormal aorta morphology | 2.72e-06 | 225 | 15 | 5 | MP:0000272 | |
| MousePheno | abnormal heart ventricle morphology | 7.93e-06 | 793 | 15 | 7 | MP:0005294 | |
| MousePheno | heart right ventricle hypertrophy | 1.12e-05 | 42 | 15 | 3 | MP:0000276 | |
| MousePheno | abnormal systemic artery morphology | 1.18e-05 | 304 | 15 | 5 | MP:0011655 | |
| MousePheno | abnormal heart right ventricle morphology | 1.85e-05 | 156 | 15 | 4 | MP:0003920 | |
| MousePheno | abnormal heart right ventricle wall morphology | 2.14e-05 | 52 | 15 | 3 | MP:0031534 | |
| MousePheno | increased heart right ventricle size | 2.54e-05 | 55 | 15 | 3 | MP:0010563 | |
| MousePheno | increased heart ventricle size | 2.91e-05 | 175 | 15 | 4 | MP:0008772 | |
| MousePheno | vascular smooth muscle hyperplasia | 4.81e-05 | 10 | 15 | 2 | MP:0005489 | |
| MousePheno | abnormal artery morphology | 6.98e-05 | 440 | 15 | 5 | MP:0002191 | |
| MousePheno | abnormal heart right ventricle size | 7.25e-05 | 78 | 15 | 3 | MP:0010577 | |
| MousePheno | abnormal vascular smooth muscle morphology | 7.53e-05 | 79 | 15 | 3 | MP:0005592 | |
| MousePheno | abnormal heart ventricle size | 8.17e-05 | 228 | 15 | 4 | MP:0031543 | |
| MousePheno | abnormal cardiac muscle tissue morphology | 1.15e-04 | 489 | 15 | 5 | MP:0010630 | |
| MousePheno | decreased chondrocyte proliferation | 1.28e-04 | 16 | 15 | 2 | MP:0014101 | |
| MousePheno | abnormal chondrocyte proliferation | 2.02e-04 | 20 | 15 | 2 | MP:0014099 | |
| MousePheno | abnormal smooth muscle morphology | 2.18e-04 | 113 | 15 | 3 | MP:0000767 | |
| MousePheno | abnormal heart ventricle wall morphology | 2.24e-04 | 296 | 15 | 4 | MP:0031532 | |
| MousePheno | enlarged heart | 2.33e-04 | 916 | 15 | 6 | MP:0000274 | |
| MousePheno | abnormal cardiac outflow tract development | 3.60e-04 | 134 | 15 | 3 | MP:0006126 | |
| MousePheno | abnormal interventricular septum morphology | 3.88e-04 | 342 | 15 | 4 | MP:0000281 | |
| MousePheno | hairpin sperm flagellum | 4.29e-04 | 29 | 15 | 2 | MP:0009243 | |
| MousePheno | increased systemic arterial blood pressure | 5.83e-04 | 158 | 15 | 3 | MP:0002842 | |
| MousePheno | abnormal heart septum morphology | 6.26e-04 | 388 | 15 | 4 | MP:0006113 | |
| MousePheno | aneurysm | 6.27e-04 | 35 | 15 | 2 | MP:0003279 | |
| MousePheno | abnormal muscle morphology | 6.49e-04 | 1106 | 15 | 6 | MP:0002108 | |
| MousePheno | overexpanded pulmonary alveolus | 7.00e-04 | 37 | 15 | 2 | MP:0001183 | |
| MousePheno | emphysema | 7.00e-04 | 37 | 15 | 2 | MP:0001958 | |
| MousePheno | abnormal muscle fiber morphology | 7.42e-04 | 406 | 15 | 4 | MP:0004087 | |
| MousePheno | abnormal aorta tunica media morphology | 7.78e-04 | 39 | 15 | 2 | MP:0009873 | |
| MousePheno | abnormal myocardium layer morphology | 7.98e-04 | 414 | 15 | 4 | MP:0005329 | |
| MousePheno | abnormal heart layer morphology | 8.58e-04 | 422 | 15 | 4 | MP:0010545 | |
| MousePheno | abnormal chondrocyte physiology | 9.03e-04 | 42 | 15 | 2 | MP:0009780 | |
| MousePheno | abnormal heart size | 9.17e-04 | 1180 | 15 | 6 | MP:0005406 | |
| MousePheno | abnormal cartilage physiology | 9.46e-04 | 43 | 15 | 2 | MP:0031306 | |
| MousePheno | increased mean systemic arterial blood pressure | 9.46e-04 | 43 | 15 | 2 | MP:0004875 | |
| MousePheno | abnormal pulmonary valve morphology | 1.04e-03 | 45 | 15 | 2 | MP:0002748 | |
| MousePheno | abnormal heart and great artery attachment | 1.24e-03 | 205 | 15 | 3 | MP:0010426 | |
| MousePheno | abnormal aorta wall morphology | 1.28e-03 | 50 | 15 | 2 | MP:0009866 | |
| MousePheno | abnormal heart and great vessel attachment | 1.29e-03 | 208 | 15 | 3 | MP:0010425 | |
| MousePheno | lung hemorrhage | 1.38e-03 | 52 | 15 | 2 | MP:0001182 | |
| MousePheno | increased myocardial fiber size | 1.43e-03 | 53 | 15 | 2 | MP:0004564 | |
| MousePheno | abnormal heart right ventricle outflow tract morphology | 1.43e-03 | 53 | 15 | 2 | MP:0010428 | |
| MousePheno | kinked sperm flagellum | 1.60e-03 | 56 | 15 | 2 | MP:0009237 | |
| MousePheno | hypertension | 1.60e-03 | 56 | 15 | 2 | MP:0000231 | |
| MousePheno | abnormal systemic arterial blood pressure | 2.07e-03 | 245 | 15 | 3 | MP:0000230 | |
| MousePheno | heart left ventricle hypertrophy | 2.15e-03 | 65 | 15 | 2 | MP:0002625 | |
| MousePheno | abnormal myocardium compact layer morphology | 2.28e-03 | 67 | 15 | 2 | MP:0004056 | |
| MousePheno | abnormal long bone epiphyseal plate proliferative zone | 2.35e-03 | 68 | 15 | 2 | MP:0003662 | |
| MousePheno | abnormal aorticopulmonary septum morphology | 2.35e-03 | 68 | 15 | 2 | MP:0010650 | |
| MousePheno | aorticopulmonary septal defect | 2.35e-03 | 68 | 15 | 2 | MP:0010651 | |
| MousePheno | abnormal snout morphology | 2.37e-03 | 257 | 15 | 3 | MP:0000443 | |
| MousePheno | abnormal pulmonary circulation | 2.42e-03 | 69 | 15 | 2 | MP:0002295 | |
| MousePheno | abnormal aortic valve morphology | 2.63e-03 | 72 | 15 | 2 | MP:0002747 | |
| MousePheno | abnormal heart left ventricle outflow tract morphology | 2.63e-03 | 72 | 15 | 2 | MP:0010429 | |
| MousePheno | abnormal blood vessel morphology | 2.92e-03 | 1472 | 15 | 6 | MP:0001614 | |
| MousePheno | abnormal skin physiology | 3.28e-03 | 288 | 15 | 3 | MP:0005501 | |
| MousePheno | abnormal chondrocyte morphology | 3.48e-03 | 83 | 15 | 2 | MP:0000166 | |
| MousePheno | abnormal truncus arteriosus septation | 3.56e-03 | 84 | 15 | 2 | MP:0010454 | |
| MousePheno | perimembraneous ventricular septal defect | 4.25e-03 | 92 | 15 | 2 | MP:0010418 | |
| Domain | EGF_3 | 1.48e-15 | 235 | 17 | 10 | PS50026 | |
| Domain | EGF-like_dom | 2.65e-15 | 249 | 17 | 10 | IPR000742 | |
| Domain | EGF-like_CS | 4.27e-15 | 261 | 17 | 10 | IPR013032 | |
| Domain | EGF_2 | 4.97e-15 | 265 | 17 | 10 | PS01186 | |
| Domain | EGF_CA | 6.08e-14 | 122 | 17 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.94e-14 | 124 | 17 | 8 | IPR001881 | |
| Domain | EGF_1 | 3.16e-13 | 255 | 17 | 9 | PS00022 | |
| Domain | EGF_CA | 6.41e-13 | 86 | 17 | 7 | PF07645 | |
| Domain | LDLR_class-A_CS | 7.93e-13 | 40 | 17 | 6 | IPR023415 | |
| Domain | Ldl_recept_a | 1.68e-12 | 45 | 17 | 6 | PF00057 | |
| Domain | - | 1.93e-12 | 46 | 17 | 6 | 4.10.400.10 | |
| Domain | LDLRA_1 | 2.52e-12 | 48 | 17 | 6 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.87e-12 | 49 | 17 | 6 | IPR002172 | |
| Domain | LDLa | 2.87e-12 | 49 | 17 | 6 | SM00192 | |
| Domain | LDLRA_2 | 2.87e-12 | 49 | 17 | 6 | PS50068 | |
| Domain | EGF | 1.23e-11 | 235 | 17 | 8 | SM00181 | |
| Domain | Growth_fac_rcpt_ | 4.49e-11 | 156 | 17 | 7 | IPR009030 | |
| Domain | EGF_Ca-bd_CS | 1.98e-10 | 97 | 17 | 6 | IPR018097 | |
| Domain | EGF_CA | 2.25e-10 | 99 | 17 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.39e-10 | 100 | 17 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.41e-10 | 106 | 17 | 6 | IPR000152 | |
| Domain | Ldl_recept_b | 4.67e-10 | 14 | 17 | 4 | PF00058 | |
| Domain | LDLRB | 4.67e-10 | 14 | 17 | 4 | PS51120 | |
| Domain | LY | 6.37e-10 | 15 | 17 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 6.37e-10 | 15 | 17 | 4 | IPR000033 | |
| Domain | - | 3.79e-08 | 39 | 17 | 4 | 2.120.10.30 | |
| Domain | EGF | 7.48e-08 | 126 | 17 | 5 | PF00008 | |
| Domain | 6-blade_b-propeller_TolB-like | 7.49e-08 | 46 | 17 | 4 | IPR011042 | |
| Domain | cEGF | 1.61e-06 | 26 | 17 | 3 | IPR026823 | |
| Domain | cEGF | 1.61e-06 | 26 | 17 | 3 | PF12662 | |
| Domain | EGF_extracell | 2.08e-05 | 60 | 17 | 3 | IPR013111 | |
| Domain | EGF_2 | 2.08e-05 | 60 | 17 | 3 | PF07974 | |
| Domain | Laminin_G | 1.25e-03 | 58 | 17 | 2 | IPR001791 | |
| Domain | - | 3.31e-03 | 95 | 17 | 2 | 2.60.120.200 | |
| Domain | Ig_I-set | 1.27e-02 | 190 | 17 | 2 | IPR013098 | |
| Domain | I-set | 1.27e-02 | 190 | 17 | 2 | PF07679 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.15e-07 | 48 | 14 | 4 | M27642 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 2.26e-06 | 100 | 14 | 4 | M27158 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.08e-05 | 45 | 14 | 3 | MM15344 | |
| Pathway | REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL | 1.92e-05 | 7 | 14 | 2 | MM15187 | |
| Pathway | REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL | 2.56e-05 | 8 | 14 | 2 | M27444 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 3.38e-05 | 198 | 14 | 4 | M18311 | |
| Pathway | REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2 | 8.28e-05 | 14 | 14 | 2 | M27263 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 9.29e-05 | 92 | 14 | 3 | MM14881 | |
| Pathway | REACTOME_ATTACHMENT_AND_ENTRY | 1.55e-04 | 19 | 14 | 2 | M41729 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.70e-04 | 300 | 14 | 4 | M610 | |
| Pathway | REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE | 1.72e-04 | 20 | 14 | 2 | M27258 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY | 2.29e-04 | 23 | 14 | 2 | M48234 | |
| Pathway | REACTOME_HS_GAG_DEGRADATION | 2.50e-04 | 24 | 14 | 2 | M636 | |
| Pathway | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | 2.94e-04 | 26 | 14 | 2 | M708 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 3.43e-04 | 143 | 14 | 3 | M27275 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 4.19e-04 | 31 | 14 | 2 | M685 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 4.24e-04 | 381 | 14 | 4 | M48063 | |
| Pathway | REACTOME_EARLY_SARS_COV_2_INFECTION_EVENTS | 5.98e-04 | 37 | 14 | 2 | M45028 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM | 7.35e-04 | 41 | 14 | 2 | M27257 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 7.74e-04 | 189 | 14 | 3 | MM14772 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 7.86e-04 | 190 | 14 | 3 | MM15687 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | 1.09e-03 | 50 | 14 | 2 | M678 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 1.42e-03 | 57 | 14 | 2 | M692 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.52e-03 | 59 | 14 | 2 | M27218 | |
| Pathway | REACTOME_HEDGEHOG_LIGAND_BIOGENESIS | 1.67e-03 | 62 | 14 | 2 | MM15181 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.74e-03 | 250 | 14 | 3 | M27554 | |
| Pathway | REACTOME_HEDGEHOG_LIGAND_BIOGENESIS | 1.84e-03 | 65 | 14 | 2 | M27439 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.90e-03 | 258 | 14 | 3 | MM14572 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 2.86e-03 | 636 | 14 | 4 | M41834 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.05e-03 | 84 | 14 | 2 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.12e-03 | 85 | 14 | 2 | M16441 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 3.96e-03 | 96 | 14 | 2 | M39581 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 4.12e-03 | 98 | 14 | 2 | M48247 | |
| Pathway | REACTOME_AMYLOID_FIBER_FORMATION | 5.16e-03 | 110 | 14 | 2 | M27958 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 6.12e-03 | 120 | 14 | 2 | M48233 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 6.72e-03 | 126 | 14 | 2 | M695 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 7.90e-03 | 137 | 14 | 2 | MM15182 | |
| Pubmed | 1.42e-08 | 167 | 17 | 5 | 22159717 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 1.28e-07 | 21 | 17 | 3 | 21337463 | |
| Pubmed | Loss of apolipoprotein E receptor LR11 in Alzheimer disease. | 2.25e-07 | 2 | 17 | 2 | 15313836 | |
| Pubmed | Gene-smoking interactions identify several novel blood pressure loci in the Framingham Heart Study. | 4.77e-07 | 32 | 17 | 3 | 25189868 | |
| Pubmed | Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells. | 6.74e-07 | 3 | 17 | 2 | 18174160 | |
| Pubmed | 6.80e-07 | 146 | 17 | 4 | 27068509 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 24760755 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 7775583 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 23651543 | ||
| Pubmed | 1.40e-06 | 175 | 17 | 4 | 28071719 | ||
| Pubmed | Thrombospondin-1 binds to ApoER2 and VLDL receptor and functions in postnatal neuronal migration. | 2.25e-06 | 5 | 17 | 2 | 18946489 | |
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 16101684 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 19047013 | ||
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 12169628 | ||
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 12242711 | ||
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 19998449 | ||
| Pubmed | 8.08e-06 | 9 | 17 | 2 | 20005821 | ||
| Pubmed | 1.23e-05 | 11 | 17 | 2 | 2745554 | ||
| Pubmed | 1.23e-05 | 11 | 17 | 2 | 24639464 | ||
| Pubmed | 1.48e-05 | 12 | 17 | 2 | 12761845 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.57e-05 | 101 | 17 | 3 | 23382219 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.57e-05 | 101 | 17 | 3 | 20551380 | |
| Pubmed | Spatiotemporal Localisation of Heparan Sulphate Proteoglycans throughout Mouse Lens Morphogenesis. | 2.04e-05 | 14 | 17 | 2 | 37408198 | |
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 2.04e-05 | 14 | 17 | 2 | 17389516 | |
| Pubmed | 2.04e-05 | 14 | 17 | 2 | 15082773 | ||
| Pubmed | No replication of genetic association between candidate polymorphisms and Alzheimer's disease. | 2.69e-05 | 16 | 17 | 2 | 19889475 | |
| Pubmed | 3.42e-05 | 18 | 17 | 2 | 10827173 | ||
| Pubmed | 4.70e-05 | 21 | 17 | 2 | 26116392 | ||
| Pubmed | 5.16e-05 | 22 | 17 | 2 | 18448648 | ||
| Pubmed | 6.17e-05 | 24 | 17 | 2 | 34653670 | ||
| Pubmed | 7.84e-05 | 27 | 17 | 2 | 24586749 | ||
| Pubmed | Lung epithelial branching program antagonizes alveolar differentiation. | 1.18e-04 | 33 | 17 | 2 | 24058167 | |
| Pubmed | The spatiotemporal expression pattern of Syndecans in murine embryonic teeth. | 1.25e-04 | 34 | 17 | 2 | 32220631 | |
| Pubmed | 1.48e-04 | 37 | 17 | 2 | 32201365 | ||
| Pubmed | 2.10e-04 | 44 | 17 | 2 | 31273033 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.13e-04 | 1201 | 17 | 5 | 35696571 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 2.26e-04 | 248 | 17 | 3 | 24006456 | |
| Pubmed | 2.30e-04 | 46 | 17 | 2 | 20301533 | ||
| Pubmed | 2.61e-04 | 49 | 17 | 2 | 21362503 | ||
| Pubmed | 2.72e-04 | 50 | 17 | 2 | 23658023 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 4.18e-04 | 62 | 17 | 2 | 28344315 | |
| Pubmed | 4.45e-04 | 64 | 17 | 2 | 36369321 | ||
| Pubmed | 4.45e-04 | 64 | 17 | 2 | 22261194 | ||
| Interaction | NTN5 interactions | 2.79e-09 | 24 | 16 | 4 | int:NTN5 | |
| Interaction | ZNF517 interactions | 6.22e-09 | 29 | 16 | 4 | int:ZNF517 | |
| Interaction | ZNF408 interactions | 7.37e-08 | 145 | 16 | 5 | int:ZNF408 | |
| Interaction | ZNF563 interactions | 8.99e-08 | 12 | 16 | 3 | int:ZNF563 | |
| Interaction | ZFP41 interactions | 1.02e-07 | 57 | 16 | 4 | int:ZFP41 | |
| Interaction | ZNF224 interactions | 4.64e-07 | 20 | 16 | 3 | int:ZNF224 | |
| Interaction | EGFL6 interactions | 5.41e-07 | 21 | 16 | 3 | int:EGFL6 | |
| Interaction | FEZF1 interactions | 1.33e-06 | 28 | 16 | 3 | int:FEZF1 | |
| Interaction | CFC1 interactions | 2.50e-06 | 126 | 16 | 4 | int:CFC1 | |
| Interaction | FOXD4L6 interactions | 7.40e-06 | 49 | 16 | 3 | int:FOXD4L6 | |
| Interaction | DKK2 interactions | 7.40e-06 | 49 | 16 | 3 | int:DKK2 | |
| Interaction | ZNF169 interactions | 9.94e-06 | 54 | 16 | 3 | int:ZNF169 | |
| Interaction | LRPAP1 interactions | 1.03e-05 | 180 | 16 | 4 | int:LRPAP1 | |
| Interaction | FBXO2 interactions | 1.25e-05 | 411 | 16 | 5 | int:FBXO2 | |
| Interaction | ANKRD36B interactions | 1.37e-05 | 60 | 16 | 3 | int:ANKRD36B | |
| Interaction | ZNF331 interactions | 1.58e-05 | 63 | 16 | 3 | int:ZNF331 | |
| Interaction | HRG interactions | 1.58e-05 | 63 | 16 | 3 | int:HRG | |
| Interaction | GPC5 interactions | 2.12e-05 | 9 | 16 | 2 | int:GPC5 | |
| Interaction | IGFL3 interactions | 2.68e-05 | 75 | 16 | 3 | int:IGFL3 | |
| Interaction | TAFA3 interactions | 3.01e-05 | 78 | 16 | 3 | int:TAFA3 | |
| Interaction | PI15 interactions | 3.63e-05 | 83 | 16 | 3 | int:PI15 | |
| Interaction | SIRPD interactions | 4.04e-05 | 86 | 16 | 3 | int:SIRPD | |
| Interaction | TIMP3 interactions | 4.62e-05 | 90 | 16 | 3 | int:TIMP3 | |
| Interaction | MDK interactions | 4.78e-05 | 91 | 16 | 3 | int:MDK | |
| Interaction | RSPO1 interactions | 6.17e-05 | 15 | 16 | 2 | int:RSPO1 | |
| Interaction | PRG2 interactions | 6.23e-05 | 285 | 16 | 4 | int:PRG2 | |
| Interaction | SCN3A interactions | 7.05e-05 | 16 | 16 | 2 | int:SCN3A | |
| Interaction | DEFB123 interactions | 7.05e-05 | 16 | 16 | 2 | int:DEFB123 | |
| Interaction | GLI4 interactions | 1.23e-04 | 125 | 16 | 3 | int:GLI4 | |
| Interaction | TNFAIP6 interactions | 2.05e-04 | 27 | 16 | 2 | int:TNFAIP6 | |
| Interaction | LRP2 interactions | 2.28e-04 | 154 | 16 | 3 | int:LRP2 | |
| Interaction | APOH interactions | 2.54e-04 | 30 | 16 | 2 | int:APOH | |
| Interaction | ITGB1BP1 interactions | 3.08e-04 | 33 | 16 | 2 | int:ITGB1BP1 | |
| Interaction | APOE interactions | 3.10e-04 | 171 | 16 | 3 | int:APOE | |
| Interaction | ZNF74 interactions | 3.27e-04 | 34 | 16 | 2 | int:ZNF74 | |
| Interaction | SOST interactions | 3.46e-04 | 35 | 16 | 2 | int:SOST | |
| Interaction | NDP interactions | 3.46e-04 | 35 | 16 | 2 | int:NDP | |
| Interaction | GREM2 interactions | 3.87e-04 | 37 | 16 | 2 | int:GREM2 | |
| Interaction | ATN1 interactions | 4.03e-04 | 187 | 16 | 3 | int:ATN1 | |
| Interaction | EMX2 interactions | 4.30e-04 | 39 | 16 | 2 | int:EMX2 | |
| Interaction | CCN2 interactions | 4.53e-04 | 40 | 16 | 2 | int:CCN2 | |
| Interaction | ZNF264 interactions | 4.76e-04 | 41 | 16 | 2 | int:ZNF264 | |
| Interaction | APBA2 interactions | 6.53e-04 | 48 | 16 | 2 | int:APBA2 | |
| Interaction | PATE1 interactions | 6.80e-04 | 49 | 16 | 2 | int:PATE1 | |
| Interaction | DYRK1A interactions | 7.79e-04 | 552 | 16 | 4 | int:DYRK1A | |
| Interaction | TYW3 interactions | 7.95e-04 | 53 | 16 | 2 | int:TYW3 | |
| Interaction | SERPINE1 interactions | 8.26e-04 | 54 | 16 | 2 | int:SERPINE1 | |
| Interaction | TAFA4 interactions | 8.56e-04 | 55 | 16 | 2 | int:TAFA4 | |
| Interaction | FGF2 interactions | 8.56e-04 | 55 | 16 | 2 | int:FGF2 | |
| Interaction | CLU interactions | 8.84e-04 | 245 | 16 | 3 | int:CLU | |
| Interaction | MAPK8IP1 interactions | 9.52e-04 | 58 | 16 | 2 | int:MAPK8IP1 | |
| Interaction | SPARC interactions | 1.19e-03 | 65 | 16 | 2 | int:SPARC | |
| Interaction | ANAPC10 interactions | 1.31e-03 | 68 | 16 | 2 | int:ANAPC10 | |
| Interaction | ZNF8 interactions | 1.38e-03 | 70 | 16 | 2 | int:ZNF8 | |
| Interaction | COBLL1 interactions | 1.63e-03 | 76 | 16 | 2 | int:COBLL1 | |
| Interaction | ZNF707 interactions | 1.76e-03 | 79 | 16 | 2 | int:ZNF707 | |
| Interaction | SNX17 interactions | 1.85e-03 | 81 | 16 | 2 | int:SNX17 | |
| Interaction | SDF2L1 interactions | 1.94e-03 | 322 | 16 | 3 | int:SDF2L1 | |
| Interaction | LRP1B interactions | 2.03e-03 | 85 | 16 | 2 | int:LRP1B | |
| Interaction | LGALS1 interactions | 2.12e-03 | 332 | 16 | 3 | int:LGALS1 | |
| Interaction | PDGFB interactions | 2.17e-03 | 88 | 16 | 2 | int:PDGFB | |
| Interaction | RLN1 interactions | 2.42e-03 | 93 | 16 | 2 | int:RLN1 | |
| Interaction | CTSG interactions | 2.53e-03 | 95 | 16 | 2 | int:CTSG | |
| Interaction | FGA interactions | 2.53e-03 | 95 | 16 | 2 | int:FGA | |
| Interaction | COL18A1 interactions | 2.69e-03 | 98 | 16 | 2 | int:COL18A1 | |
| Interaction | HSPG2 interactions | 2.69e-03 | 98 | 16 | 2 | int:HSPG2 | |
| Interaction | TTR interactions | 2.80e-03 | 100 | 16 | 2 | int:TTR | |
| Interaction | SYT1 interactions | 3.08e-03 | 105 | 16 | 2 | int:SYT1 | |
| Interaction | FGG interactions | 3.08e-03 | 105 | 16 | 2 | int:FGG | |
| Interaction | DAB1 interactions | 3.19e-03 | 107 | 16 | 2 | int:DAB1 | |
| Interaction | EDN3 interactions | 3.25e-03 | 108 | 16 | 2 | int:EDN3 | |
| Interaction | NOS1AP interactions | 3.55e-03 | 113 | 16 | 2 | int:NOS1AP | |
| Interaction | MAPK8IP2 interactions | 3.68e-03 | 115 | 16 | 2 | int:MAPK8IP2 | |
| Interaction | LYZL1 interactions | 3.87e-03 | 118 | 16 | 2 | int:LYZL1 | |
| Interaction | GIPC1 interactions | 3.93e-03 | 119 | 16 | 2 | int:GIPC1 | |
| Interaction | SULF2 interactions | 3.93e-03 | 119 | 16 | 2 | int:SULF2 | |
| Interaction | CACNA1A interactions | 4.19e-03 | 123 | 16 | 2 | int:CACNA1A | |
| Interaction | ZDHHC15 interactions | 4.33e-03 | 125 | 16 | 2 | int:ZDHHC15 | |
| Interaction | INSIG1 interactions | 4.46e-03 | 127 | 16 | 2 | int:INSIG1 | |
| Interaction | THBS1 interactions | 4.46e-03 | 127 | 16 | 2 | int:THBS1 | |
| Interaction | ZSCAN21 interactions | 4.53e-03 | 128 | 16 | 2 | int:ZSCAN21 | |
| Interaction | FBLN1 interactions | 4.60e-03 | 129 | 16 | 2 | int:FBLN1 | |
| Interaction | SYNJ2BP interactions | 4.74e-03 | 131 | 16 | 2 | int:SYNJ2BP | |
| Interaction | SCGB1D1 interactions | 4.88e-03 | 133 | 16 | 2 | int:SCGB1D1 | |
| Interaction | GFI1B interactions | 5.10e-03 | 136 | 16 | 2 | int:GFI1B | |
| Interaction | MFAP4 interactions | 5.32e-03 | 139 | 16 | 2 | int:MFAP4 | |
| Interaction | DAB2 interactions | 5.39e-03 | 140 | 16 | 2 | int:DAB2 | |
| Interaction | CFH interactions | 5.39e-03 | 140 | 16 | 2 | int:CFH | |
| Interaction | CST1 interactions | 5.47e-03 | 141 | 16 | 2 | int:CST1 | |
| Interaction | KLK15 interactions | 6.25e-03 | 151 | 16 | 2 | int:KLK15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 2.22e-04 | 325 | 17 | 3 | chr9q34 | |
| GeneFamily | Low density lipoprotein receptors | 6.36e-08 | 13 | 12 | 3 | 634 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.91e-03 | 161 | 12 | 2 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 6.97e-03 | 193 | 12 | 2 | 594 | |
| Coexpression | NABA_MATRISOME | 1.69e-06 | 1008 | 17 | 7 | MM17056 | |
| Coexpression | NABA_MATRISOME | 1.90e-06 | 1026 | 17 | 7 | M5889 | |
| Coexpression | FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN | 5.93e-06 | 6 | 17 | 2 | M14136 | |
| Coexpression | GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN | 7.10e-06 | 199 | 17 | 4 | M8070 | |
| Coexpression | AMIT_EGF_RESPONSE_240_HELA | 7.20e-06 | 59 | 17 | 3 | M7714 | |
| Coexpression | NABA_CORE_MATRISOME | 2.36e-05 | 270 | 17 | 4 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 2.53e-05 | 275 | 17 | 4 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.40e-04 | 191 | 17 | 3 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.59e-04 | 196 | 17 | 3 | M3008 | |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP | 2.67e-04 | 198 | 17 | 3 | M9534 | |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN | 2.71e-04 | 199 | 17 | 3 | M9532 | |
| Coexpression | GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_UP | 2.75e-04 | 200 | 17 | 3 | M7279 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 6.00e-05 | 97 | 17 | 3 | GSM777043_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | 7.42e-05 | 976 | 17 | 6 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 7.48e-07 | 193 | 17 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic-Chondrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.28e-07 | 198 | 17 | 4 | 55f013e9e6587d9ece59751fa131b1d22d6cceea | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.28e-07 | 198 | 17 | 4 | c72ef2ddcbb6dacbed4c6200d89e17d57314dcdc | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-07 | 200 | 17 | 4 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-07 | 200 | 17 | 4 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 2.58e-05 | 154 | 17 | 3 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 157 | 17 | 3 | fc127e7720649e746f3d3f5c2e9e63784767106a | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 157 | 17 | 3 | 66a191cef4aa00811bb04462310d012610006f85 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 158 | 17 | 3 | a2efcc184ef13d81373e3690253ba35f6be09c5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 158 | 17 | 3 | ba9998cbf786c515d30fe42de02c7a246db1b6f9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 158 | 17 | 3 | e52eff2bd1e7e0ce9c278ed5109802865e0fe69c | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.23e-05 | 166 | 17 | 3 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-plasmacytoid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.23e-05 | 166 | 17 | 3 | 1ca888ae8168707493f19ee52a89d7c70e6cb51d | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.23e-05 | 166 | 17 | 3 | 4cba4ca1aa2321b9ef7cd230932b890d2434a252 | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 172 | 17 | 3 | 24ecfda5e43e28f190089770cd2eae5bf2ed292b | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 172 | 17 | 3 | db5a31cafce4346fe459d7f35210823fd7004439 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.71e-05 | 174 | 17 | 3 | 2479e4804253f55647d2192e40566d713419c51b | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_macrophage|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.71e-05 | 174 | 17 | 3 | 7f1e26b58b66f4ac4c3bc315354bd620ad782eaa | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 175 | 17 | 3 | 5552ff1e13f931c8cd7780726c90b5609497a648 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.84e-05 | 176 | 17 | 3 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 4.18e-05 | 181 | 17 | 3 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.32e-05 | 183 | 17 | 3 | 06e4b05d86a7d643569e19575c2c9aa351d33f29 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 183 | 17 | 3 | c7ef8ee2b3fcfa69cea0fdcb2041674b832933db | |
| ToppCell | facs-Pancreas-Exocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 183 | 17 | 3 | c9d9d7dd629ce6787502103b158a07e8684a66f8 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 183 | 17 | 3 | 92eee4bdd84965ae0bd1ed1c7f26a3b83ad0cdac | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.46e-05 | 185 | 17 | 3 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-05 | 186 | 17 | 3 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.53e-05 | 186 | 17 | 3 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | facs-Lung-EPCAM-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 186 | 17 | 3 | 7c4eb769574f9f32753cea1cc38c711dabba88b9 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.53e-05 | 186 | 17 | 3 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.68e-05 | 188 | 17 | 3 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.75e-05 | 189 | 17 | 3 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-05 | 189 | 17 | 3 | 37ce47abd6f96df04d35a4a6189d007bef5ccc94 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-05 | 189 | 17 | 3 | b55324cb365a827d071952709bbf0e8ef8c313de | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.75e-05 | 189 | 17 | 3 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.75e-05 | 189 | 17 | 3 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-05 | 189 | 17 | 3 | 62e46d59d3b89d4566b595c704d8b02f1ea9060b | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 190 | 17 | 3 | 9d5242759546be0089981ef1877e4ed5f81face5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-05 | 190 | 17 | 3 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-05 | 190 | 17 | 3 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-05 | 190 | 17 | 3 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.90e-05 | 191 | 17 | 3 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.90e-05 | 191 | 17 | 3 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.90e-05 | 191 | 17 | 3 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 192 | 17 | 3 | bcd8876235be503186f119653b39476488c0fa15 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 192 | 17 | 3 | f4cd65e6c5b17bcabf45fe5b687246c72e7975f7 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 192 | 17 | 3 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-05 | 192 | 17 | 3 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.98e-05 | 192 | 17 | 3 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 192 | 17 | 3 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.98e-05 | 192 | 17 | 3 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.98e-05 | 192 | 17 | 3 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.98e-05 | 192 | 17 | 3 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 192 | 17 | 3 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-05 | 192 | 17 | 3 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 193 | 17 | 3 | 5d42979d811ee13a07dee08a3743a90776017cb4 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 193 | 17 | 3 | 95e64b9580d30c28702639a043a8b72ce1cadeb6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.06e-05 | 193 | 17 | 3 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 193 | 17 | 3 | 97c0730aad9135ac681250b3871cc094a28f80a7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.06e-05 | 193 | 17 | 3 | 2c15186d15545804cc262da9137ab825609d4b2c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.06e-05 | 193 | 17 | 3 | 00349d176fb6a46cbcc99c41d975651b6e9aaad4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-05 | 193 | 17 | 3 | cc355b2ed6510619cad969ae074126d7c8db784d | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.13e-05 | 194 | 17 | 3 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.13e-05 | 194 | 17 | 3 | 7bf6edefd13047e04665dbe34051ef3f481f85a4 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.13e-05 | 194 | 17 | 3 | 19e5beae2c1f8bf42cbe618e89810ce7b01a396c | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|World / Lineage and Cell class | 5.13e-05 | 194 | 17 | 3 | c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9 | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|World / Lineage and Cell class | 5.21e-05 | 195 | 17 | 3 | 69723b06c2a5c2aaf4d10874b11bca7f06822bdc | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.21e-05 | 195 | 17 | 3 | 36c784709ee32174e05b457500339c3b8eee3244 | |
| ToppCell | COVID-19-Heart-Low_count_Fib|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.21e-05 | 195 | 17 | 3 | e09590d1f51d5fa57fceb84c9f48f84b23d4d224 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.21e-05 | 195 | 17 | 3 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | distal-Hematologic-EREG+_Dendritic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.29e-05 | 196 | 17 | 3 | c17bb7b3992bfec194bfa310f201a5c64b35868e | |
| ToppCell | distal-Hematologic-EREG+_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.29e-05 | 196 | 17 | 3 | 14c6870d125fc2bdacf4199883399cec0dd3f569 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 196 | 17 | 3 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 196 | 17 | 3 | a20a56d8997d6db2a10046c8801c619a379de83c | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 196 | 17 | 3 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.37e-05 | 197 | 17 | 3 | 3332b9b5bf78f0203ebbd94257a36e9054d896c3 | |
| ToppCell | distal-2-Hematologic-Classical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.37e-05 | 197 | 17 | 3 | 9a1c9221904ad1e46e64e3785516804e87128adc | |
| ToppCell | distal-2-Hematologic-EREG+_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.37e-05 | 197 | 17 | 3 | 6fcca7c071e35786b715adeb18be317d34315d7e | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class | 5.37e-05 | 197 | 17 | 3 | cb321836980e7b4efbb9284c6af7ccd34079d2be | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.54e-05 | 199 | 17 | 3 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.62e-05 | 200 | 17 | 3 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Kidney|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 5.62e-05 | 200 | 17 | 3 | 1f99afa1f3c32a2a9cfb4ad33ff4d404e34fac63 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.62e-05 | 200 | 17 | 3 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.62e-05 | 200 | 17 | 3 | 93e13937ec74418a697c37d56f57509fb2154780 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.25e-04 | 98 | 17 | 2 | cb0941481aef9068d7dbce0d1b6cf125f482a98d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.25e-04 | 98 | 17 | 2 | a74fb790c135bd0d0033df3aca7b789d8b25e361 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.59e-04 | 115 | 17 | 2 | ac73aa06e617ed791c6ae9e38189bac74188c27b | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.06e-03 | 128 | 17 | 2 | 3ca9ae69fb8cb7f8acb7540aa71778bc917da4df | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.11e-03 | 131 | 17 | 2 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-03 | 132 | 17 | 2 | a1fda8c5287168c4f159203ed27cadfb4ce1b131 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.25e-03 | 139 | 17 | 2 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-03 | 139 | 17 | 2 | b07929348ec9ad95d7bce33a7deac0938227b19f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.27e-03 | 140 | 17 | 2 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.30e-03 | 142 | 17 | 2 | f4e4cde228149d5a536fbf0517ed71d81e296faf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-03 | 142 | 17 | 2 | 5b6b0c611c83b23ef7289854a515b78f6cf84500 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-03 | 144 | 17 | 2 | 5665dd2839b6c8ddbf5ddb2d22e1ee6073f74c3b | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-03 | 144 | 17 | 2 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-03 | 144 | 17 | 2 | c0c5f254a960ba5e5f1354599d54e77360e6c2ac | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-03 | 144 | 17 | 2 | 1efa434e577d1f87e02df01667782f414d63bd60 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.40e-03 | 147 | 17 | 2 | c5913cc351577e54536dd239a33e5f7a5cb79672 | |
| Computational | Genes in the cancer module 236. | 1.73e-04 | 18 | 12 | 2 | MODULE_236 | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.62e-07 | 197 | 17 | 5 | 6043_UP | |
| Drug | monatepil | 1.25e-06 | 29 | 17 | 3 | CID000060810 | |
| Drug | Epi Lovastatin | 3.91e-06 | 341 | 17 | 5 | CID000003962 | |
| Drug | AC1L1J6H | 2.41e-05 | 236 | 17 | 4 | CID000004889 | |
| Drug | epicholesterol | 7.84e-05 | 636 | 17 | 5 | CID000000304 | |
| Drug | pitavastatin | 7.90e-05 | 114 | 17 | 3 | CID005282451 | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | 1.42e-04 | 373 | 17 | 4 | ctd:C540355 | |
| Drug | ezetimibe | 1.68e-04 | 147 | 17 | 3 | CID000150311 | |
| Drug | simvastatin | 1.69e-04 | 390 | 17 | 4 | CID000054454 | |
| Drug | sodium cholate | 2.01e-04 | 408 | 17 | 4 | CID000000303 | |
| Drug | 25-hydroxycholesterol | 2.15e-04 | 160 | 17 | 3 | CID000065094 | |
| Drug | probucol | 2.23e-04 | 162 | 17 | 3 | CID000004912 | |
| Drug | pyrachlostrobin | 2.45e-04 | 811 | 17 | 5 | ctd:C513428 | |
| Drug | vitamin E | 2.71e-04 | 441 | 17 | 4 | CID000002116 | |
| Drug | Withaferin A [5119-48-2]; Down 200; 1uM; PC3; HT_HG-U133A | 3.00e-04 | 179 | 17 | 3 | 4554_DN | |
| Drug | thapsigargin; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.00e-04 | 179 | 17 | 3 | 7103_DN | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A | 3.15e-04 | 182 | 17 | 3 | 1663_DN | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 3.74e-04 | 193 | 17 | 3 | 5584_DN | |
| Drug | AC1OAGKW | 3.74e-04 | 193 | 17 | 3 | CID006857413 | |
| Drug | Iopanoic acid [96-83-3]; Down 200; 7uM; MCF7; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 5448_DN | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 2284_DN | |
| Drug | Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 3284_UP | |
| Drug | Reserpinic acid hydrochloride; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 7323_UP | |
| Drug | Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 7022_UP | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; HL60; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 2426_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 1639_DN | |
| Drug | AH23848 hemicalcium salt hydrate; Down 200; 1uM; MCF7; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 6890_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 5438_DN | |
| Drug | Cinoxacin [28657-80-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 3463_UP | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 4507_UP | |
| Drug | Trimethadione [127-48-0]; Up 200; 28uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 4165_UP | |
| Drug | Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 3363_DN | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 2212_DN | |
| Drug | Sulfameter [651-06-9]; Up 200; 14.2uM; HL60; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 2712_UP | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 2761_UP | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 3182_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 4729_UP | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 5459_DN | |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 5729_DN | |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 3419_UP | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 5628_UP | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 6812_UP | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 4358_UP | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 3581_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Up 200; 13.2uM; HL60; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 6145_UP | |
| Drug | Adrenosterone [382-45-6]; Up 200; 13.4uM; HL60; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 3107_UP | |
| Drug | Karakoline [39089-30-0]; Up 200; 10.6uM; HL60; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 2203_UP | |
| Drug | Khellin [82-02-0]; Up 200; 15.4uM; PC3; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 6641_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Up 200; 25.2uM; PC3; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 4311_UP | |
| Drug | Epiandrosterone [481-29-8]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 3306_UP | |
| Drug | Chlorzoxazone [95-25-0]; Up 200; 23.6uM; MCF7; HT_HG-U133A | 4.15e-04 | 200 | 17 | 3 | 7456_UP | |
| Drug | Oxantel pamoate [68813-55-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 4.15e-04 | 200 | 17 | 3 | 2632_UP | |
| Drug | Myricetin [529-44-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 4.15e-04 | 200 | 17 | 3 | 4170_UP | |
| Drug | FR139317 | 4.65e-04 | 43 | 17 | 2 | CID000107810 | |
| Drug | Proxyl-opc | 4.87e-04 | 44 | 17 | 2 | CID000124490 | |
| Disease | colorectal cancer, overall survival | 9.72e-05 | 29 | 15 | 2 | EFO_0000638, MONDO_0005575 | |
| Disease | pack-years measurement, systolic blood pressure | 1.34e-04 | 34 | 15 | 2 | EFO_0006335, EFO_0006526 | |
| Disease | FEV/FEC ratio | 2.62e-04 | 1228 | 15 | 5 | EFO_0004713 | |
| Disease | functional brain measurement | 7.82e-04 | 82 | 15 | 2 | EFO_0007849 | |
| Disease | carotid artery intima media thickness | 1.40e-03 | 450 | 15 | 3 | EFO_0007117 | |
| Disease | non-alcoholic fatty liver disease, type 2 diabetes mellitus | 1.40e-03 | 110 | 15 | 2 | EFO_0003095, MONDO_0005148 | |
| Disease | peak expiratory flow | 1.87e-03 | 498 | 15 | 3 | EFO_0009718 | |
| Disease | Alzheimer's disease (is_implicated_in) | 2.01e-03 | 132 | 15 | 2 | DOID:10652 (is_implicated_in) | |
| Disease | insomnia, total blood protein measurement | 2.51e-03 | 148 | 15 | 2 | EFO_0004536, EFO_0004698 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.69e-03 | 566 | 15 | 3 | EFO_0007660, EFO_0008354 | |
| Disease | Craniofacial Abnormalities | 2.79e-03 | 156 | 15 | 2 | C0376634 | |
| Disease | Paroxysmal atrial fibrillation | 2.79e-03 | 156 | 15 | 2 | C0235480 | |
| Disease | Persistent atrial fibrillation | 2.79e-03 | 156 | 15 | 2 | C2585653 | |
| Disease | familial atrial fibrillation | 2.79e-03 | 156 | 15 | 2 | C3468561 | |
| Disease | vital capacity | 2.89e-03 | 1236 | 15 | 4 | EFO_0004312 | |
| Disease | Atrial Fibrillation | 2.93e-03 | 160 | 15 | 2 | C0004238 | |
| Disease | brain volume measurement | 3.10e-03 | 595 | 15 | 3 | EFO_0006930 | |
| Disease | COVID-19, mortality | 3.30e-03 | 170 | 15 | 2 | EFO_0004352, MONDO_0100096 | |
| Disease | attempted suicide | 3.61e-03 | 178 | 15 | 2 | EFO_0004321 | |
| Disease | macula measurement | 4.06e-03 | 189 | 15 | 2 | EFO_0008375 | |
| Disease | chronic obstructive pulmonary disease | 4.66e-03 | 688 | 15 | 3 | EFO_0000341 | |
| Disease | optic disc size measurement | 4.75e-03 | 205 | 15 | 2 | EFO_0004832 | |
| Disease | Colorectal Carcinoma | 4.93e-03 | 702 | 15 | 3 | C0009402 | |
| Disease | ceramide measurement | 6.19e-03 | 235 | 15 | 2 | EFO_0010222 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NGYLEDGEECDCGEE | 421 | Q9H013 | |
| DYLCDGQEDCEDGSD | 301 | P98160 | |
| VCYCEGEESGEGDRG | 21 | Q9BUH6 | |
| GDFDCADGSDERNCE | 3536 | Q9NZR2 | |
| DDDGGCDDYAEGRVC | 351 | Q16538 | |
| VEQVSGDCDDEDGCG | 491 | P78333 | |
| ADGAGCEDVDECLEG | 4706 | Q8NDA2 | |
| VCDGDVDCTDGYDEN | 2971 | P98164 | |
| EVCNGVDDCGDGTDE | 3901 | P98164 | |
| DGYDDCGDLSDEQNC | 326 | Q9Y5Q5 | |
| GTCDDVDECQEYGPE | 1001 | Q8N2S1 | |
| GEDDDEDRACGFCQS | 226 | Q8NEL9 | |
| GYQGEGRQCEDIDEC | 76 | Q9NQ36 | |
| AAVFVCDGDDDCGDG | 181 | Q14114 | |
| GMDDCGDYSDEANCE | 1346 | Q92673 | |
| QEDYDKDGIGDACDD | 726 | P07996 | |
| DYLEEMEACEDGGCQ | 51 | A6NEH6 | |
| EDIYDCVPCEDGGDD | 156 | P52735 |